Loading...
Please wait, while we are loading the content...
Novel Mutations in SH2D1A Gene in X-linked Lymphoproliferative Syndrome, Diagnosed After B-Cell Non-Hodgkin Lymphoma
| Content Provider | Semantic Scholar |
|---|---|
| Author | Sharapova, Svetlana O. Fedorova, Alina S. Pashchenko, O. E. Vahliarskaya, Svetlana S. Guryanova, Irina E. Migas, Alexandr A. Kondratenko, Irina Aleinikova, Olga V. |
| Copyright Year | 2017 |
| Abstract | Background: X-linked lymphoproliferative disease type I (XLP I) is caused by mutations in the SH2D1A gene and characterized mainly by hypogammaglobulinemia and abnormal response to Epstein-Barr virus with a high predisposition to B-cell non-Hodgkin lymphoma development. Observations: In this article, we describe the experience of 2 centers in Belarus and in Russia that follow 3 male patients who were diagnosed with XLP I after lymphoma development and treatment. Three novel mutations c.51G>C (p.E17D), c.192G>T (p.W64C), and c.53insA (p.K18KfsX67) were found in 3 males patients with XLP I. Two of them did not have any signs of immunodeficiency before B-cell non-Hodgkin lymphoma development. Conclusions: We propose SH2D1A mutational screening be considered in male patients with or without hypogammaglobulinemia who received rituximab treatment for lymphoma and did not recover immunoglobulin G in a year after B-depleting therapy. |
| File Format | PDF HTM / HTML |
| DOI | 10.1097/MPH.0000000000000815 |
| PubMed reference number | 28267077 |
| Journal | Medline |
| Volume Number | 39 |
| Alternate Webpage(s) | https://oncology.by/books/publications/inostrannie/CLINICAL%20AND%20LABORATORY%20OBSERVATIONS.pdf |
| Alternate Webpage(s) | https://doi.org/10.1097/MPH.0000000000000815 |
| Journal | Journal of pediatric hematology/oncology |
| Language | English |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Article |